Cerebral amyloid angiopathy (CAA): non-haemorrhagic features
Evidence-based neurology checklist on cerebral amyloid angiopathy (caa): non-haemorrhagic features: Ischaemic features Multiple subcortical white matter hyperintensities (WMH) Silent acute ischaemic lesions Small vessel disease (SVD) Lobar lacunes: unlike deep lacunes of hypertension Pseudotumours…
Ischaemic features
- Multiple subcortical white matter hyperintensities (WMH)
- Silent acute ischaemic lesions
- Small vessel disease (SVD)
- Lobar lacunes: unlike deep lacunes of hypertension
Pseudotumours
Other non-haemorrhagic features
Amyloid PET scan features
Acronym
References
- Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. JNNP 2012; 83:124-137.
- Mehndiratta P, Manjila S, Ostergard T, Eisele S, Cohen ML, Sila C, Selman WR. Cerebral amyloid angiopathy-associated intracerebral hemorrhage: pathology and management. Neurosurg Focus 2012; 32:E7.
- Charidimou A, Boulouis G, Haley K, et al. White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy. Neurology 2016; 86:505-511.
- Boulouis G, Charidimou A, Jessel MJ, et al. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage. Neurology 2017; 88:878-884.
- Biffi A, Halpin A, Towfighi A. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010; 75:693–698.
- And 9 more. Subscribe to see the full list
Related checklists
- Cerebral amyloid angiopathy (CAA): classification
- Cerebral amyloid angiopathy (CAA): haemorrhage types
- Cerebral amyloid angiopathy (CAA): Boston diagnostic criteria
- Cerebral amyloid angiopathy (CAA): clinical features
- Cerebral amyloid angiopathy (CAA): transient focal neurological episodes (TFNEs)
- Cerebral amyloid angiopathy (CAA): intracerebral haemorrhage (ICH)
